# Oncology

## Cancer Statistics

### Leading Cancer Cases

|Rank|Female|Male|
|-|-|-|
|1|Breast|Prostate|
|2|Lung|Lung|
|3|Colorectal|Colorectal|
|4|Melanoma|Melanoma|

### Leading Cancer Deaths

|Rank|Female|Male|
|-|-|-|
|1|Lung|Lung|
|2|Colorectal|Colorectal|
|3|Pancreas|Pancreas|
|4|Breast|Prostate|

## Cancer Screening

|Cancer|Population|Age (years)|Tests|Interval (years)|
|-|-|-|-|-|
|Breast|All|50 ~ 75|Mammography|2|
|Cervical|All|20 ~ 65|Pap smear|3|
||All|30 ~ 65|Pap smear<br>HPV testing|5|
|Colon|All|50 ~ 75|Fecal occult blood testing|1|
||||Sigmoidoscopy|5|
||||Colonoscopy|10|
|Lung|Smoker|50 ~ 80|Low-dose CT|1|

### Earlier Cancer Screening

- Breast: 10 years earlier than the first affected relative
- Cervical: 3 years after first sexual activity
- Colon: 10 years earlier than the first affected relative

## Oncogenes

|Gene|Products|Tumors|
|-|-|-|
|ABL1|Tyrosine kinase|CML|
|BCL2|Anti-apoptotics|Follicular lymphoma|
|BRAF|Serine/Threonine kinase (STK)|Melanoma|
|EGFR<br>[HER1]<br>[ERBB1]|Tyrosine kinase|Non-small cell lung cancer (NSCLC)<br>Colorectal cancer|
|NEU<br>[HER2]<br>[ERBB2]|Tyrosine kinase|Breast cancer|
|C-KIT|Tyrosine kinase|Gastrointestinal stromal tumor (GIST)|
|C-MYC|Transcription factor|Burkitt lymphoma|
|L-MYC|Transcription factor|Small cell lung cancer (SCLC)|
|N-MYC|Transcription factor|Neuroblastoma|
|KRAS|GTPase|Lung cancer<br>Colorectal cancer<br>Pancreatic cancer|
|RET|Tyrosine kinase|MEN 2A & 2B|

## Tumor Suppressor Genes

|Gene|Products|Tumors|
|-|-|-|
|APC|-|Familial adenomatous polyposis (FAP)|
|ATM|DNA repair|Ataxia telangiectasia|
|BRCA|DNA repair|Breast cancer<br>Ovarian cancer|
|ERCC|DNA repair|Xeroderma pigmentosum|
|FANC|DNA repair|Fanconi anemia|
|MEN1|Menin|MEN 1|
|MLH1<br>MSH2|DNA repair|Lynch syndrome|
|NF1<br>NF2|RAS activators|<br>Neurofibromatosis (NF) type 1<br>Neurofibromatosis (NF) type 2|
|P16|CDK inhibitors|Melanoma|
|P53|Transcription factor for P21|Li-Fraumeni syndrome|
|PTEN|-|Breast cancer<br>Prostate cancer<br>Endometrial cancer|
|RB|E2F inhibitors|Retinoblastoma<br>Osteosarcoma|
|TSC1<br>TSC2|Hamartin<br>Tuberlin|Tuberous sclerosis|
|VHL|HIF inhibitors|Von Hippel-Lindau (VHL) disease|
|WT1<br>WT2|-|Wilms tumor|

## Tumor Markers

|Marker|Tumors|
|-|-|
|5-HIAA|Carcinoid tumors|
|AFP|Hepatocellular carcinoma<br>Germ cell tumors (GCT)|
|ALP|Bone metastasis<br>Liver metastasis<br>Seminoma|
|CA 125|Ovarian cancer|
|CA 15-3<br>CA 27-29|Breast cancer|
|CA 19-9|Pancreatic adenocarcinoma|
|CEA|Colorectal cancer<br>Pancreatic adenocarcinoma|
|Calcitonin|Medullary thyroid carcinoma|
|Chromogranin<br>Synaptophysin<br>NSE|Neuroendocrine tumors (NET)|
|Desmin|Myoma<br>Myosarcoma|
|GFAP|Glioma<br>Glioblastoma<br>Schwannoma|
|hCG|Hydatidiform moles<br>Germ cell tumors (GCT)|
|HVA<br>VMA|Pheochromocytoma|
|Keratin|Carcinoma|
|Neurofilament|Neuroblastoma|
|PSA|Prostate cancer|
|S-100|Neural crest tumors<br>Histiocytosis|
|TRAP|Hairy cell leukemia|
|Vimentin|Sarcoma|

## Paraneoplastic Syndromes

|Syndrome|Cancer|
|-|-|
|ACTH|Small cell carcinoma|
|hCG|Large cell carcinoma|
|Lambert-Eaton myasthenic syndrome|Small cell carcinoma|
|Myasthenia gravis|Thymoma|
|PTHrP|Squamous cell carcinoma<br>Renal cell carcinoma|
|SIADH|Small cell carcinoma|
|Acanthosis nigricans|Visceral malignancy|
|Erythema nodosum|Non-Hodgkins lymphoma|
|Migratory thrombophlebitis<br>Trousseau syndrome|Pancreatic adenocarcinoma|
|Necrolytic migratory erythema|Glucagonoma|
|Seborrheic keratosis<br>Leser-Tr√©lat sign|Visceral malignancy|
|Dermatomyositis|Malignancy|

## Cancers Associated with Virus

|Virus|Cancers|
|-|-|
|HBV<br>HCV|Liver cancer|
|HPV|Cervical cancer<br>Oropharyngeal cancer|
|EBV|Burkitt lymphoma<br>CNS lymphoma<br>Nasopharyngeal cancer<br>Lymphoproliferative disease|
|HHV8|Kaposi sarcoma|
|HTLV|T-cell leukemia|

## Common Bone Metastases

- Breast cancer
- Prostate cancer
- Lung cancer
- Kidney cancer
- Thyroid cancer

## Workup of Suspected Bone Metastases

|Imaging|Indications|
|-|-|
|Bone scan|Prostate cancer<br>Small cell lung cancer<br>Hodgkin lymphoma|
|PET|Breast cancer<br>Multiple myeloma<br>Non-small cell lung cancer<br>Non-Hodgkin lymphoma|

## Embryonal Tumors

- Neuroblastoma
- Medulloblastoma
- Pineoblastoma
- Retinoblastoma
- Nephroblastoma

## Presentation of Neurofibromatosis Type 1

- Bone dysplasia
- Cafe-au-lait spots
- Lisch nodules
- Neurofibroma
- Optic glioma
- Pheochromocytoma

## Presentation of Neurofibromatosis Type 2

- Vestibular schwannoma :: bilateral
- Cataract
- Meningioma
- Ependymoma

## Presentation of Tuberous Sclerosis {HAMARTOMAS}

- Hamartoma
- Angiofibroma
- Mitral regurgitation
- Ash-leaf spot
- Rhabdomyoma :: heart
- Tubers :: cortex
- Autosomal dominant
- Mental retardation
- Angiomyolipoma :: kidney
- Seizure
- Shagreen patch

## Presentation of Sturge-Weber Syndrome {STURGE-L}

- Sporadic
- Stain :: nevus flammeus
- Tram-track calcification
- Unilateral
- Retardation
- GNAQ gene
- Glaucoma
- Epilepsy
- Episcleral hemangioma
- Leptomeningeal angiomatosis

## Presentation of von Hippel-Lindau (VHL) Disease {HARP}

- Hemangioblastoma
- Angiomatosis
- Renal cell carcinoma (RCC)
- Pheochromocytoma

## Li-Fraumeni [SBLA] Syndrome {SBLA}

- Sarcoma
- Breast cancer
- Leukemia
- Adrenal tumor

## Syndromes Associated with Wilms Tumor

### WAGR Syndrome {WAGR}

- Wilms tumor [Nephroblastoma]
- Aniridia
- Genitourinary anomaly
- Retardation

### Beckwith-Wiedemann Syndrome

- Macrosomia
- Macroglossia
- Hemihyperplasia
- Organomegaly
- Abdominal wall defects
- Wilms tumor [Nephroblastoma]
- Embryonal tumors

## Syndromes Associated with Colorectal Cancer

### Gardner Syndrome

- Familial adenomatous polyposis (FAP)
- Osteomas
- Soft tissue tumors
- Congenital hypertrophy of retinal pigment epithelium (RPE)
- Impacted / Supernumerary teeth

### Turcot Syndrome

- Colorectal cancer
	- Familial adenomatous polyposis (FAP)
	- Hereditary nonpolyposis colorectal cancer (HNPCC)
- CNS tumors
	- Medulloblastoma
	- Glioma

### Lynch Syndrome

- Hereditary nonpolyposis colorectal cancer (HNPCC)
- Endometrial cancer

## Target Therapy

|Mechanism|Medication|Indications|
|-|-|-|
|BRAF inhibitors|Vemurafenib|Melanoma|
|C-KIT inhibitors|Imatinib|Gastrointestinal stromal tumor (GIST)|
|EGFR inhibitors|Cetuximab|Colorectal cancer|
||Gefitinib<br>Erlotinib|Non-small cell lung cancer (NSCLC)|
|HER2 inhibitors|Trastuzumab|Breast cancer|
|VEGF inhibitors|Bevacizumab|Solid tumors|
|VEGFR inhibitors|Sunitinib<br>Sorafenib|Cancer|
||Regorafenib|Colorectal cancer (CRC)|

![](../Figures/Target%20Therapy.png)

## Immunotherapy

|Mechanism|Medication|
|-|-|
|TLR7 activators|Imiquimod|
|CTLA-4 inhibitors|Ipilimumab|
|PD-1 inhibitors|Nivolumab<br>Pembrolizumab|
|PD-L1 inhibitors|Atezolizumab<br>Avelumab<br>Durvalumab|

## Side Effects of Chemotherapy

|Side Effect|Drugs|
|-|-|
|Immunosuppression|-|
|Marrow toxicity|-|
|Nephrotoxicity|Platinums|
|Ototoxicity|Platinums|
|Neurotoxicity|Nitrosoureas<br>Platinums<br>Vincas<br>Taxanes|
|Cardiotoxicity|Anthracyclines<br>Trastuzumab|
|Pulmonary fibrosis|Bleomycin<br>Busulfan|
|Hemorrhagic cystitis|Cyclophosphamide|

## Cancers Treated with Radiotherapy Only

|Mnemonic|Cancer|
|-|-|
|O|Oral|
|N|Nasopharyngeal|
|L|Laryngeal|
|Y|Lymphoma|
|Cure|Cervical|
|Possible|Prostate|
